[3] [4] In the Phase 2 trial published in the New England Journal of Medicine (2023), participants receiving retatrutide achieved substantial reductions in body weight over 24 weeks, with higher doses associated with mean weight losses of approximately 17% of body weight
Men are not immune to gallstone formation during rapid weight loss
[32] [33] The efficacy of melatonin in disease treatment has been the subject of limited trials, with most available data deriving from small-scale, preliminary studies
Brett Osborn, a Florida neurologist and longevity expert, agreed that the availability of the first generic GLP-1 is "great news." The generics lower price point is particularly beneficial for people who have chronic conditions like diabetes, Osborn noted "where long-term medication use is necessary to prevent downrange effects like vascular disease, strokes and heart attacks , cancer, neurodegenerative diseases like Alzheimers, and obesity, the latter of which is also a gateway disease," he said
